Valuation: Novartis AG

Capitalization 254B 217B 202B 190B 350B 23,033B 383B 2,355B 914B 10,859B 955B 934B 39,626B P/E ratio 2025 *
18.3x
P/E ratio 2026 * 18.1x
Enterprise value 274B 234B 218B 205B 378B 24,839B 413B 2,539B 986B 11,711B 1,029B 1,007B 42,733B EV / Sales 2025 *
4.95x
EV / Sales 2026 * 4.91x
Free-Float
87.19%
Yield 2025 *
3.08%
Yield 2026 * 3.21%
More valuation ratios * Estimated data
Dynamic Chart

Last Transcript: Novartis AG

1 day-0.45%
1 week-1.48%
Current month+0.98%
1 month-0.23%
3 months+6.73%
6 months+8.58%
Current year+18.94%
More quotes
1 week 103.14
Extreme 103.14
107.88
1 month 99.45
Extreme 99.45
108.18
Current year 81.1
Extreme 81.1
108.18
1 year 81.1
Extreme 81.1
108.18
3 years 73.74
Extreme 73.74
108.18
5 years 72.84
Extreme 72.84
108.18
10 years 65.09
Extreme 65.09
108.18
More quotes
Manager TitleAgeSince
Chief Executive Officer 49 2018-01-31
Director of Finance/CFO 60 2013-04-23
Chief Tech/Sci/R&D Officer 63 2022-05-15
Director TitleAgeSince
Director/Board Member 66 2014-12-31
Director/Board Member 68 2015-12-31
Director/Board Member 60 2015-12-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.45%-1.48%+20.24%+24.41% 254B
+1.80%+1.70%+30.21%+186.49% 920B
+0.75%+4.78%+44.31%+18.06% 510B
-0.29%-1.22%+28.81%+35.52% 395B
-0.35%+1.90%+25.12%+3.11% 340B
-1.12%-1.09%+28.43%+18.70% 278B
+1.30%+0.58%-1.67%-9.57% 249B
+0.45%+3.73%-57.41%-30.85% 224B
+0.11%-3.68%+17.41%+16.70% 171B
-2.28%-0.68%+31.08%+35.66% 149B
Average -0.01%+0.45%+16.65%+29.82% 349.14B
Weighted average by Cap. +0.42%+1.07%+22.26%+59.05%
See all sector performances

Financials

2025 *2026 *
Net sales 55.48B 47.27B 44.11B 41.48B 76.38B 5,023B 83.56B 514B 199B 2,368B 208B 204B 8,641B 56.73B 48.34B 45.1B 42.42B 78.1B 5,136B 85.45B 525B 204B 2,422B 213B 208B 8,837B
Net income 14.37B 12.24B 11.42B 10.74B 19.78B 1,301B 21.64B 133B 51.65B 613B 53.91B 52.76B 2,238B 14.27B 12.16B 11.35B 10.67B 19.65B 1,292B 21.5B 132B 51.3B 609B 53.55B 52.41B 2,223B
Net Debt 19.95B 17B 15.86B 14.92B 27.46B 1,806B 30.05B 185B 71.71B 852B 74.85B 73.25B 3,107B 24.17B 20.59B 19.22B 18.07B 33.27B 2,188B 36.4B 224B 86.88B 1,032B 90.69B 88.75B 3,765B
More financial data * Estimated data
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (29.3%); - immunology (18.5%); - cardiovascular, renal and metabolic diseases (17%); - neuroscience (9.4%). The remaining net sales (25.8%) are from contract manufacturing of pharmaceutical products. At the end of 2024, Novartis AG had over 30 production sites worldwide. Net sales are distributed geographically as follows: Europe (30.9%), the United States (42%), Asia/Africa/Australasia (20%), Canada and Latin America (7.1%).
Employees
75,883
More about the company
Date Price Change Volume
25-12-12 105.50 CHF -0.45% 1,978,600
25-12-11 105.98 CHF +0.53% 2,333,253
25-12-10 105.42 CHF -1.31% 3,227,200
25-12-09 106.82 CHF +0.17% 2,451,246
25-12-08 106.64 CHF -0.41% 3,019,489

Delayed Quote Swiss Exchange, December 12, 2025 at 11:31 am EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
132.58USD
Average target price
135.31USD
Spread / Average Target
+2.06%
Consensus

Quarterly revenue - Rate of surprise